一. 承担国自然面上项目4项、市局级课题10余项 二. 2021年获中华人民共和国教育部 科技进步一等奖,「提高肝病患者围术期救治质量的保障体系建立与关键技术」 三. 重要论文 1. Shunpeng Xing#, Daxiang Wen#, Ling Zhu, Jiemin Wang, Zhe Li, Liqun Yang*, Yuan Gao*. Magnet guidance reduces misplacement of subclavian vein catheter in internal jugular vein. Intensive Care Med. 2017;43: 711–712. (IF:12.015) 2. Yuetian Yu#, Chunyan Liu#, Zhongheng Zhang, Hui Shen , Yujie Li , Liangjing Lu* and Yuan Gao*. Bronchoalveolar lavage fluid dilution in ICU patients: what we should know and what we should do. Crit Care 2019 Jan 24;23(1): 23.(IF:19.334, 2022) 3. Juan Gao#, Junnan Guo#, Jianxiao Chen#, Chenling Ding, Jiemin Wang, Qian Huang, Ying Jian, Xianyuan Zhao, Min Li,* Yuan Gao,* Chaoyong Yang,* and Wei Wang. d-Amino Acid-Based Metabolic Labeling Enables a Fast Antibiotic Susceptibility Test of Both Isolated Bacteria and Bronchoalveolar Lavage Fluid. Adv Healthc Mater. 2022 Mar;11(6):e2101736. (IF:11.092) 4. Shuya Mei# , Qiaoyi Xu#, Yue Hu, Ri Tang, Jinhua Feng, Yang Zhou, Shunpeng Xing, Yuan Gao*, Zhengyu He*. Integrin β3-PKM2 pathway-mediated aerobic glycolysis contributes to mechanical ventilation-induced pulmonary fibrosis. Theranostics. 2022 Aug 15;12(14):6057-6068. (IF:11.6) 5. Fangfang Sun , Yanwei Lin , Xiaodong Wang , Yuan Gao *, Shuang Ye *. Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection. Lancet Infect Dis. 2022 Sep;22(9):1279. (IF:71.421) 6. Zhe Li, Yuan Gao*, Zhanqi Zhao. Volume-OXygenation Index to Predict HFNC Failure: How to Capture the Tidal Volume Matters. Am J Respir Crit Care Med. 2023, 207(4):490- 491. (IF:30.528) 7. Ri Tang # , Shuya Mei # , Qiaoyi Xu 1, Jinhua Feng 1, Yang Zhou 1, Shunpeng Xing, Zhengyu He*, Yuan Gao*. ASK1-ER stress pathway-mediated fibrotic-EV release contributes to the interaction of alveolar epithelial cells and lung fibroblasts to promote mechanical ventilation- induced pulmonary fibrosis. Exp Mol Med. 2022, 54(12):2162-2174. (IF:12.153) 8. Zhujun Cao#, Weiyi Gao#, Hong Bao#, Haiyan Feng#, Shuya Mei#, Peizhan Chen, Yueqiu Gao, Zhilei Cui, Qin Zhang, Xianmin Meng, Honglian Gui, Weijing Wang, Yimei Jiang, Zijia Song, Yiqing Shi, Jing Sun, Yifei Zhang, Qing Xie, Yiping Xu*, Guang Ning*, Yuan Gao*, Ren Zhao*. VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19. N Engl J Med. 2023;388(5):406-417. (IF: 176.079)